KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 19 filers reported holding KAZIA THERAPEUTICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $264,000 | -19.8% | 31,420 | +8.3% | 0.00% | -100.0% |
Q3 2021 | $329,000 | +14.6% | 29,020 | 0.0% | 0.00% | – |
Q2 2021 | $287,000 | -17.3% | 29,020 | +3.6% | 0.00% | -100.0% |
Q1 2021 | $347,000 | +14.1% | 28,020 | -20.5% | 0.00% | 0.0% |
Q4 2020 | $304,000 | -30.3% | 35,260 | -45.4% | 0.00% | 0.0% |
Q3 2020 | $436,000 | – | 64,590 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Transform Wealth, LLC | 106,245 | $35,000 | 0.01% |
UBS Group AG | 1,546 | $5,000 | 0.00% |
Renaissance Technologies | 34,325 | $115,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
BREWIN DOLPHIN LTD | 32 | $107 | 0.00% |
MORGAN STANLEY | 63,017 | $210,000 | 0.00% |
AdvisorNet Financial, Inc | 5 | $0 | 0.00% |